Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 1/2004

01-01-2004 | Editorial

Electronic processing of papers

Authors: Julia Heidelmann, Hans-Jörg Senn

Published in: Supportive Care in Cancer | Issue 1/2004

Login to get access

Excerpt

Happy New Year to all our readers! We hope you started 2004 well and full of new ideas. This editorial is rather unusual, coming not only from the Editor-in-Chief but also from the publisher. The use of computers has become a fact of life at home and at work, and the work of the editorial offices of science journals has not been spared this change. Accordingly, Springer-Verlag, the publisher, and the Journal have decided to take up this contemporary challenge and introduce a computer-based manuscript tracking system. We are happy to announce that this change has now been completed. …
Metadata
Title
Electronic processing of papers
Authors
Julia Heidelmann
Hans-Jörg Senn
Publication date
01-01-2004
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 1/2004
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-003-0571-4

Other articles of this Issue 1/2004

Supportive Care in Cancer 1/2004 Go to the issue

Original Article

Multicenter, randomized trial of ramosetron plus dexamethasone versus ramosetron alone in controlling cisplatin-induced emesis

Review Article

Gastrointestinal mucositis: a new biological model

Original Article

The burden of the ‘RA RA’ positive: survivors’ and hospice patients’ reflections on maintaining a positive attitude to serious illness

Letter to the Editor

Letter to the Editor

Forthcoming Meetings

January 2004

Original Article

Does tumor status influence cancer patients’ satisfaction with the doctor-patient interaction?
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits